EUVIMEDEUVIMED entdecken
Crossref

Can Ganciclovir and Quercetin‐P188 Ameliorate Cytomegalovirus Induced Hearing Loss?

Daniel Suarez, Andrew Kjar, Boston Scott, Katrina Hillam, Elizabeth Vargis, Christopher Nielson, Elizabeth Sommer, Emily Zhang, Anna Holley, Abigail Traxler, Maura Hughes, Yong Wang und 3 weitere

The Laryngoscope · 2024

DOI: 10.1002/lary.30975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Daniel Suarez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology - Head and Neck Surgery, Primary Children's Medical Center, University of Utah, Salt Lake City, Utah, U.S.A. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Hearing Loss, Deafness. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Utah State University, University of Utah Blanch Presidential Endowed Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Determine whether combination therapy with ganciclovir (GCV) and a Quercetin‐P188 solution improves hearing outcomes in a murine cytomegalovirus (CMV) model.

Methods

BALB/c mice were infected with murine CMV on postnatal day 3 (p3). Quercetin was solubilized in saline using P188 (QP188). Treatment groups received either GCV, QP188, GCV and QP188, or P188 delivery vehicle BID at 12‐hour intervals via intraperitoneal injection. All treatment groups were treated for 14 days starting at p3. Uninfected controls were treated with the combined regimen, saline or P188 delivery vehicle. Auditory thresholds were assessed using distortion product otoacoustic emission (DPOAE) and auditory brainstem response (ABR) testing at 4, 6, and 8 weeks of age. Temporal bones from separate CMV‐infected groups were harvested at p10, and viral load was determined by quantitative polymerase chain reaction.

Results

CMV‐infected mice receiving combination therapy GCV+QP188 demonstrated statistically significant lower ABR ( p < 0.001) and DPOAE thresholds ( p < 0.001) compared with mice treated with GCV monotherapy, QP188 monotherapy, and P188 delivery vehicle at 4, 6, and 8 weeks of age. GCV+QP188 combination therapy, GCV monotherapy, and QP188 monotherapy resulted in a nonsignificant reduction in mean viral titers compared to P188 monotherapy ( p = 0.08).

Conclusion

Combining GCV with the excipients quercetin and P188 effectively ameliorated CMV‐induced sensorineural hearing loss in a murine model. This result may be partially explained by a reduction in viral titers in mouse temporal bones that correlate with in vitro studies demonstrating additive antiviral effect in cell culture. Level of Evidence NA Laryngoscope , 134:1457–1463, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsHearing LossDeafnessAnimalsMiceGanciclovirCytomegalovirusQuercetinAntiviral Agents

Stichwörter der Autor:innen

BALB/cantiviralcombination therapycongenital hearing losscytomegalovirusflavonoidganciclovirmouse modelpoloxamer 188quercetinsensorineural hearing loss

Substanzen

GanciclovirQuercetinAntiviral Agents

Autor:innen und Institutionen

  • Division of Otolaryngology - Head and Neck Surgery, Primary Children's Medical Center, University of Utah, Salt Lake City, Utah, U.S.A.
  • Department of Surgery, University of Utah, Salt Lake City, Utah, U.S.A.
  • Department of Biological Engineering, Utah State University, Logan, Utah, U.S.A.

ORCID-Profile: Albert H Park

Förderung

  • Utah State University
  • University of Utah Blanch Presidential Endowed Research Grant

Zitieren

APA

Suarez, D., Kjar, A., Scott, B., Hillam, K., Vargis, E., Nielson, C., Sommer, E., Zhang, E., Holley, A., Traxler, A., Hughes, M., Wang, Y., Firpo, M. A., Britt, D., & Park, A. H. (2024). Can Ganciclovir and Quercetin‐P188 Ameliorate Cytomegalovirus Induced Hearing Loss?. The Laryngoscope. https://doi.org/10.1002/lary.30975

Vancouver

Suarez D, Kjar A, Scott B, Hillam K, Vargis E, Nielson C, et al. Can Ganciclovir and Quercetin‐P188 Ameliorate Cytomegalovirus Induced Hearing Loss?. The Laryngoscope. 2024. doi:10.1002/lary.30975

BibTeX
@article{Suarez2024,
  author = {Suarez, Daniel and Kjar, Andrew and Scott, Boston and Hillam, Katrina and Vargis, Elizabeth and Nielson, Christopher and Sommer, Elizabeth and Zhang, Emily and Holley, Anna and Traxler, Abigail and Hughes, Maura and Wang, Yong and Firpo, Matthew A and Britt, David and Park, Albert H},
  title = {Can Ganciclovir and Quercetin‐P188 Ameliorate Cytomegalovirus Induced Hearing Loss?},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.30975}
}
Kostenlos starten →